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Abstract: A chemical investigation of an ethyl acetate extract of the Red Sea soft coral 
Sarcophyton glaucum has led to the isolation of two peroxide diterpenes, 11(S) 
hydroperoxylsarcoph-12(20)-ene (1), and 12(S)-hydroperoxylsarcoph-10-ene (2), as well 
as 8-epi-sarcophinone (3). In addition to these three new compounds, two known structures 
were identified including: ent-sarcophine (4) and sarcophine (5). Structures were elucidated 
by spectroscopic analysis, with the relative configuration of 1 and 2 confirmed by X-ray 
diffraction. Isolated compounds were found to be inhibitors of cytochrome P450 1A activity 
as well as inducers of glutathione S-transferases (GST), quinone reductase (QR), and 
epoxide hydrolase (mEH) establishing chemo-preventive and tumor anti-initiating activity 
for these characterized metabolites. 
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1. Introduction 
Marine natural products are diverse in terms of chemical structures as well as biological activities. 
The Red Sea serves as an epicenter for marine bio-diversity with a high endemic biota. Indeed of the 
180 soft corals species identified world-wide, approximately 40% are native to the Red Sea [1]. Soft 
corals are marine invertebrates possessing a vast range of terpenoid metabolites. These terpenes, 
mostly cembranoids, represent the main chemical defense for coral against natural predators [2]. Soft 
corals of the genus Sarcophyton (family Alcyoniidae) are particularly rich in cembrane terpenes [3]. 
Cembranoids contain a 14-membered macro cyclic skeleton and exhibit a wide range of   
biological activities including anti-tumor, neuro-protective, antimicrobial, calcium-antagonistic, and 
anti-inflammatory activity [4–7]. The cembranoid diterpene sarcophine has been investigated since 
1998 for its potential as a chemo-preventive agent [8], cytotoxic agent, anti-microbial agent [9], 
competitive cholinesterase inhibitor [10], noncompetitive phosphofructokinase inhibitor [11], and a 
Na
+, K
+-ATPase inhibitor [12]. Recent studies focusing on the treatment of human diseases have 
shown that sarcophine and sarcophine derivatives (e.g., hydroxylated sarcophine) are potent cancer 
chemo-preventive agents [8,9,13–15].  
Cancer chemoprevention is based on chemical constituents that block, inhibit, or reverse the 
development of cancer in normal or pre-neoplastic tissue [16]. During the past 20 years, thousands of 
novel marine metabolites have been identified and assayed for anticancer activity [17]. Most of these 
drug leads are identified by high-throughput in vitro screening via a cost-effective testing of cancer 
cell lines derived from human and rodent sources. Indeed several marine-derived drug leads have 
reached phase II human clinical trials based on promising anticancer results, although toxicity testing 
has mostly screened out such candidate drugs. Sarcophine anti-tumor potency appears to at least in part 
involve inhibition of cell transformation that can be induced in vitro by 12-O-tetradecanoyl  
phorbol-13-acetate (TPA) with irreversible acquisition of tumorigenicity [7,13]. In many cases, 
carcinogenesis is initiated by pro-carcinogens in combination with phase I enzymes such as 
cytochrome P450 1A and oxidative stress leading to DNA damage. This process can be mitigated at 
least in part by phase II detoxification enzymes such as glutathione S-transferases (GSTs), quinone 
reductase (QR), and epoxide hydrolase (mEH).  
Herein, we report the isolation of three new and two known cembranolides (Chart 1) from an ethyl 
acetate extraction of the Red Sea soft coral Sarcophyton glaucum. Structures of these isolated 
metabolites were elucidated by 1D and 2D spectroscopic techniques, while the absolute configuration 
of 1 and 2 were confirmed by X-ray diffraction and circular dichroism (CD) analyses. Compounds 2 
and 3 were found to be promising inhibitors of cytochrome P450 1A activity as well as inducers of GST 
and QR activity in in vitro assays. Mar. Drugs 2012, 10 
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Chart 1. Structures of metabolites 1–5. 
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2. Results and Discussion 
Freshly collected specimens of S. glaucum were immediately frozen in dry ice and kept at −20 °C 
until ready for organic-solvent extraction. The EtOAc-soluble fraction was subjected to normal and 
reverse phase chromatography to afford new hydroperoxyl cembranolides (1 and 2), a cembrene 
derivative 8-epi-sarcophinone (3) along with two known cembranolides, ent-sarcophine (4) [18,19], 
and sarcophine (5) [18–21].  
Preliminary 
1H NMR analysis established that all fractions shared a common carbon skeleton, 
differing either in the degree of oxidation or the configuration of one or more chiral centers. Precedent 
from soft coral literature led to the assumption of a cembranoid-skeleton backbone [19]. Compound 1 
was obtained as colorless crystals, []
25
D α  +12.6  (c 0.09, CHCl3). The HR-FAB-MS exhibited a   
[M + Na]
+ ion at m/z 371.18281, indicating a molecular formula of C20H28O5Na and seven degrees of 
unsaturation that was supported by NMR data. An IR spectrum indicated the presence of an   
α,β-unsaturated-γ-lactone (1750 and 1686 cm
−1), a carbonyl (1707 cm
−1), an olefin (1669 cm
−1),  
an epoxide (1256 cm
−1) and a broad absorption band for OH stretching (3000–3353 cm
−1). The   
13C NMR and DEPT spectrum (Table 1) exhibited 20 carbon signals establishing: three methyls, seven 
methylenes, four methines, and six quaternary carbons. The spectrum also revealed the presence of an 
exomethylene functionality at δC 113.4/144.5, two oxymethine carbons at δC 60.8 and 86.5, one 
oxygenated quaternary carbon at δC 61.1, and two olefinic carbons at δC 119.6 and 146.0.  
The low field oxymethine carbon at δC 86.5 (C-11) suggested the presence of a peroxide functionality 
that is consistent with the presence of a broad singlet at δH 8.25 in the 
1H NMR spectrum [18].  
13C NMR analysis indicated that two oxygens contribute to an α,β-unsaturated-γ-lactone with 
appropriate signals at δC 174.5 and 78.9 for the carbonyl and oxymethine carbons, respectively. The 
olefinic methyl group at δH 1.85 (H3-17) exhibited an HMBC correlation with a low-filed 
13C NMR 
resonance for a keto group in association with the α,β-unsaturated-γ-lactone ring at δC 174.5 (C-16). 
Carbon signals at δC 124.2 (C-15) and 162.2 (C-1) were consistent with α and β olefinic carbons of the  
α,β-unsaturated-γ-lactone system. The carbon signal at δC 78.9 (C-2) is consistent with an oxymethine Mar. Drugs 2012, 10 
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carbon while the oxymethine proton at δH 5.50 (d, J = 15.0 Hz; H-2) exhibited a strong correlation 
with a one-proton doublet at δH 5.09 (J = 15.0 Hz; H-3) in the 
1H-
1H COSY spectrum (Figure 1). The 
olefinic methyl group at δH 1.94 (H-18) also shows an HMBC correlation with an olefinic methine at 
δC 119.6 (C-3). The methyl signal at δH 1.27 (H-19) indicates a proximal oxygen functionality 
identified from 
13C NMR to be an epoxide. The location of the epoxide ring at C7/C-8 was detected 
from HMBC correlations (Figure 1), as there are clear correlations between C-7 (δC 60.8) and H-6 
(2.59, td, J = 5.0, 13.5 Hz; 2.39, m), H-5 (2.20, m; 2.39, m), H3-19, and H-9 (1.30, m; 1.79, m); and 
between C-8 (δC 61.1) and H-7 (2.50, dd, J = 4.5, 8.5 Hz), H-9, H-10, and H-6. A triplet-like signal at 
δH 4.35 (J = 5.0 Hz; H-11) revealed the presence of a peroxide at δC 86.5 that showed a strong 
correlation with methylene signals at δH 1.50 (m) and 1.70 (m) (H-10) in the 
1H-
1H COSY spectrum 
(Figure 1). The position of the peroxide was established through HMBC correlation between H-11 and 
C-9 (32.1, t), C-10 (26.7, t), C-12 (144.5, s), and C-13 (30.1, t). Exomethylene protons at δH 5.12 (s) 
and 5.16 (s) (H2-20) showed strong correlations with carbon signals at δC 113.4 (C-20) and δC 144.5 
(C-12) in HMQC and HMBC analyses, respectively. 
Table 1. 
1H and 
13C NMR spectral data of 1–3. 
Position 
1 2  3 
δH (J in Hz)  δC  δH (J in Hz)  δC  δH (J in Hz)  δC 
1 --  162.2  --  162.5  --  163.3 
2  5.50 (d, 15.0)  78.9  5.44 (d, 16.0)  79.2  5.47 (dd, 1.5, 10.0)  78.9 
3  5.09 (d, 15.0)  119.6  4.98 (d, 16.0)  118.9  5.12 (brd, 10.5)  122.1 
4 --  146.0  --  146.7  --  141.9 
5 2.20  (m) 
2.39 (m) 
35.9 2.02  (m) 
2.38 (dt, 4.5, 13.5) 
37.1 2.66  (m) 
2.76 (m) * 
37.9 
6  2.59 (td, 5, 13.5) 
2.39 (m) 
25.4  1.77 (m)  25.0  2.06 (m) 
2.73 (m) * 
32.8 
7  2.50 (d, 4.5, 8.5)  60.8  2.53 (dd, 5.0, 6.0)  59.0  --  212.1 
8 --  61.1  --  59.2  2.44  (m)  46.6 
9 1.30  (m) 
1.79 (m) 
32.1 2.25  (m) 
2.46 (m) 
39.0 1.56  (m) 
1.95 (m) 
32.4 
 
10 1.50  (m) 
1.70 (m) 
26.7  5.42 (ddd, 16.0, 
10.5, 7.5) 
124.6 1.88  (brd,  11.0) 
2.26 (m) 
26.5 
11  4.35 (t like, 5)  86.5  5.56 (d, 16.0)  136.1  4.78 (td, 7.5, 1)  124.1 
12 --  144.5  --  84.0  --  134.9 
13 2.07  (m) 
2.20 (m) 
30.1  1.41 (dd, 4) * 
2.07 (td, 13.0, 4.5) 
37.6 1.92  (m) 
2.00 (m) 
36.1 
14 2.07  (m) 
1.50 (m) 
24.8  2.42 (m) * 
2.50 (m) * 
21.2  2.16 (brt, 12.0) 
2.60 (m) 
26.1 
15 --  124.2  --  123.8  --  122.3 
16 --  174.5  --  174.9  --  175.0 
17  1.85 (s)  8.9  1.87 (brs)  9.1  1.82 (t, 1.5)  8.9 
18  1.94 (s)  16.0  1.89 (s)  16.2  1.84 (s)  16.2 
19  1.27 (s)  16.7  1.30 (s)  18.2  1.06 (d, 7.5)  18.8 
20  5.12 (s)  113.4  1.43 (s)  22.8  1.60 (s)  15.7 
 
-OOH 
5.16 (s) 
8.25 (brs) 
 
-- 
 
7.70 (brs) 
 
-- 
 
-- 
 
-- 
a Recorded in CDCl3 and obtained at 500 and 125 MHz for 
1H and 
13C NMR, respectively. *
 Overlapping signals. Mar. Drugs 2012, 10 
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Figure 1. Selected 
1H-
1H COSY (▬) and HMBC (→) correlations of 1–3. 
Comparison of the above data with those structural relatives isolated from the same   
species [22,23], strongly indicated a cembranoid molecular framework containing the rare   
11-peroxid-12(20)-exomethylene as confirmed by X-ray analysis (Figure 2). The relative configuration 
of 1 was determined on the basis of coupling constants and NOESY experiments. The vicinal coupling 
constant of 15.0 Hz between H-2 and H-3 as well as a NOESY correlation of H-2 with H3-18 
established a trans configuration between the γ-lactone (H-2) and the olefinic proton (H-3). In order to 
confirm the position of the peroxyl group, as well as the relative stereochemistry, X-ray structure 
analysis was performed. The absolute stereochemistry of 1 at C-2 was determined via circular 
dichroism (CD) analysis (Figure 3). The observed positive Cotton effect {[θ]248 +0.7} followed by a 
negative value {[θ]225  −3.23} observed in the CD spectrum for the electronic transitions of the   
2(5H)-furanone moiety, indicated a left hand (M) helix configuration for the five-membered   
α,β-unsaturated-γ-lactone ring [24]. Supporting CD data for 1, CD spectral comparison between 1 and 
ent-sarcophine (4) indicated the same R absolute configuration for the two compounds at   
C-2 [18,19,21,22]. Therefore, 1 was assigned as 11(S)-hydroperoxylsarcoph-12(20)-ene.  
Figure 2. ORTEP depiction for X-ray crystal structures of 1–2. 
1  2
Compound  2 was obtained as color-less crystals, []
25
D α  −20.1 (c 0.1, CHCl3) with much of the 
spectral data identical to 1 (Table 1). The HR-FAB-MS showed an [M + Na]
+ ion at m/z 371.18293 
indicating a molecular formula C20H8O5Na and seven degrees of unsaturation that was supported by 
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NMR data. The analysis of 
1H, 
13C NMR and DEPT spectra revealed the presence of four methyls, five 
methylenes, five methines (two of them oxygenated, δC 59.0, and 79.2) , and six quaternary carbons 
(two of them oxygenated, δC 59.2, and 84.0). NMR spectra also revealed the presence of four olefinic 
functionalities at δC 118.9, 124.6, 136.1 and 146.7. The presence of an α,β-unsaturated-γ-lactone 
functionality was assigned based on NMR parallels with 1. From HMBC (Figure 1), a methyl unit 
(1.43, s; H3-20) was observed proximal to C-12 determined from correlations between C-12 (δC 84.0) 
and H3-20 (1.43, s), H-11 (5.56, d, J = 16.0 Hz), H-10 (5.42, ddd, J = 16.0, 10.5, 7.5 Hz), H-13 (2.07, 
td, J = 13.0, 4.5 Hz; 1.41, dd, J = 4 Hz, overlapped with H3-18). HMBC correlations (Figure 1) were 
also observed between C-7 (δC 59.0) and H-6 (1.77, m, 2H), H-5 (2.02, m; 2.38, dt, J = 4.5, 13.5 Hz), 
H3-19 (1.30, s), and H2-9 (2.25, m; 2.46, m), and C-8 (δC 59.2) and H-7 (2.53, dd, J = 5.0, 6.0 Hz),  
H2-9 (2.25, m; 2.46, m), H-10 (5.42), and H2-6 (1.77, m, 2H) indicating the same epoxide location as 
in 1 bridging C-7 and C-8. The olefinic proton signal at δH 5.56 (H-11, d, J = 16.0 Hz) showed an 
HMBC correlation with an oxygenated carbon at δC 84.0 (C-12), a methyl signal at δC 22.8 (C-20), and 
an olefinic carbon at δC 124.6 (C-10) establishing that the peroxyl and double bond functionalities are 
located at C-12 and C-10/C-11, respectively. 
The combined spectral data indicated a cembranoid molecular framework containing a rare   
12-peroxid-10-ene. This chemical configuration was confirmed by X-ray analysis (Figure 2) and 
HMBC correlations (Figure 1). The relative configuration of 2 was determined on the basis of coupling 
constants and NOESY experiments. The germinal coupling between H-2 and H-3 (16.0 Hz) and a 
NOESY correlation between H-2 and H3-18 indicated a trans configuration between the γ-lactone (H-2) 
and olefinic protons (H-3). The absolute stereochemistry of 2 was determined via CD analysis with the 
CD spectra (Figure 3) of 2 nearly equivalent with 1 and 4 establishing the same (R) configuration at  
C-2 [18,19,21,22]. Therefore, compound 2 was assigned to be 12-hydroperoxylsarcoph-10-ene (2). 
Figure 3. Circular dichroism (CD) spectra of 1–4. 
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Compound 3 was obtained as a color-less oil, []
25
D α  +19.2 (c 0.1, CHCl3). The HR-FAB-MS showed 
an [M + Na]
+ ion at m/z 339.19313 suggesting a molecular formula of C20H28O3Na that was supported 
by NMR data. Spectral data suggested that 3 was similar to the sarcophinone previously isolated from 
the soft coral Sarchophyton molle Tix [23], except for an up-field shift for H3-19 (δH 1.06) and an 
11-Hydroperoxylsarcoph-11(20)-en (1) 
12-Hydroperoxylsarcoph-10-ene (2) 
ent-Sarcophine (4) 
8-epi-Sarcophinone (3) Mar. Drugs 2012, 10 
 
 
215
increase in its coupling constant (7.5 Hz) in comparison with sarcophinone H3-19 (δH 1.13,   
J = 6.4 Hz). This up-field shift for such a methyl attached to a methine carbon can be explained by an 
alternative stereochemistry since the β-configuration methyl group is down-field relative to the   
α-stereochemistry [23,24].  
The location of the ketone carbonyl group at C-8 was determined from HMBC data that established 
clear correlations with H-8 (δH 2.44, m)/H3-19 (δH 1.06, d, J = 7.5), H-9 (δH 1.56 and 1.95, m, 2H),  
H-6 (δH 2.06 and 2.73, m, 2H), and H-5 (δH 2.66 and 2.76, m, 2H) (Figure 1). The absolute 
stereochemistry at C-2 was determined by CD analysis in which the spectrum was dominated by 
negative and positive Cotton effects {[θ]245  −1.9, [θ]220 +4.8} (Figure 3) due to the electronic 
transitions of the 2(5H)-furanone moiety [15]. These Cotton effects indicated a right-handed (P) helix 
for the five-membered α,β-unsaturated-γ-lactone ring. Similar CD spectra for 3 and sarcophine (5) 
show a common S configuration at C-2 [11,12,14,15]. Compound 3 was therefore identified as   
8-epi-sarcophinone. There are two reports that have the same structure as 3 and are referred to as  
iso-sarcophinone [25,26]; however with an absence of spectral data, direct comparisons cannot be 
made. In a more comprehensive study of iso-sarcophinone by Su et al. [23] full 
1H and 
13C NMR data 
is provided and the reported compound is an epimer of 3 with the opposite stereochemistry at C-8; this 
epimer of 3 has also been named as iso-sarcophinone. Since only spectral data comparisons are 
possible for the Su et al. study [23] and the NMR data for compound 3 reported here are not consistent 
with iso-sarcophinone, we propose that iso-sarcophinone has not been isolated in the present study but 
instead a new 8-epi-sarcophinone as shown in 3. Whether 8-epi-sarcophinone was isolated and not 
appropriately named or iso-sarcophinone was isolated but incorrectly identified by Czarkie et al. [25] 
is uncertain with an absence of key spectral data. With this study, spectral data is now available for 
both iso-sarcophinone [23] and 8-epi-sarcophinone.  
To examine the anti-cancer activity of characterized S. glaucum metabolites, individual components 
were assayed for inhibition of the phase I enzyme cytochrome P450 1A since the enzyme in 
combination with pro-carcinogens and/or oxidative stress can lead to DNA damage. Compounds 2, 3, 
and 4 were identified as inhibitors of Cyp1A activity (p < 0.01) with IC50 values of 2.7, 3.7 and 3.4 nM 
respectively (Figure 4), compared with the initial activity of β-naphthoflavone-stimulated cells. 
Assayed compounds 1 and 5 exhibited insignificant inhibition of Cyp1A activity (p > 0.05). 
To examine induction of protective enzymes of oxidative stress by characterized S. glaucum 
metabolites, individual components were assayed for induction of glutathione-S-transferase activity, 
quinone reductase (QR) and epoxide hydrolase (mEH). GSTs are responsible for the detoxification of 
a wide range of substrates including xenobiotics as well as occupational and environmental 
carcinogens such as pesticides and polycyclic aromatic hydrocarbons [27]. Total GST activity was 
investigated in cultured Hepa1c1c7 cells. Forty eight hours after murine hepatoma cell culture 
incubation with 10 µg/mL of each metabolite, total GSTs activity was significantly induced by 2–3  
(p < 0.01 and p < 0.05, respectively) (Figure 5A). While free thiols that serve as non-enzymatic 
antioxidants assisting in counteracting the deleterious effect of ROS were significantly elevated in cell 
cultures only when treated with 2 (10 µg/mL) (p < 0.05) (Figure 5A).  
QR that is induced coordinately with other Phase II enzymes such as GSTs and contributes   
to quinone detoxification was investigated in murine hepatoma cell culture. After 48 h incubation,  
2–3 resulted in a significant induction of QR activity (p < 0.01 and p < 0.05, respectively) (Figure 5B). Mar. Drugs 2012, 10 
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In contrast, epoxide hydrolase mEH, an important metabolic enzyme that catalyzes the addition of 
water to alkene epoxides and arene oxides [28] was significantly elevated in cell cultures only when 
treated with 4 (10 µg/mL) (p < 0.05) (Figure 5C).  
Figure 4. Enzyme regulation of cancer metabolism by extracted soft coral components. 
Cytochrome P450 1A inhibition (assayed concentration 1 µg/mL, mean ± SD, n = 4). 
Asterisk (*) indicates significant different p < 0.05. 
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Figure 5. Anti-initiating activity through the modulation of carcinogen metabolism. Effect 
of treatment with 10 µg/mL of each sample for 48 h on glutathione-S-transferase activity 
(bars) and non-enzymatic antioxidant activity GSH (circles) (A), quinone reductase (QR) 
(B) and epoxide hydrolase mEH (C) activities in Hepa1c1c7 cells. Data expressed as   
mean ± SD (n = 4). 
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Figure 5. Cont. 
 
3. Experimental Section 
3.1. General Experimental Procedures 
1H and 
13C NMR spectra were recorded in CDCl3 on a Varian MercuryPlus 300 MHz and Varian 
Unity INOVA 500 spectrometer (300/500 MHz for 
1H and 75/125 MHz for 
13C, respectively). All 
chemical shifts (δ) are given in ppm units with reference to TMS as an internal standard and the 
coupling constants (J) are given in Hz. FAB-MS was performed on a Finnigan LCQ ion trap mass 
spectrometer and HR-FAB-MS experiments were performed on Fourier transform ion cyclotron mass 
spectrometer (Ion Spec, Varian). The spectra were recorded by infusion into the ESI (electrospray 
ionization) source using chloroform as the solvent. High performance liquid chromatography (HPLC) 
was performed on an Agilent pump equipped with an Agilent-G1314 variable wavelength UV detector 
at 254 nm and a semi-preparative reverse-phase column (Econosphere™, RP-C18, 5 μm, 250 × 4.6 mm). 
Optical rotation was determined at 589 nm (sodium D line) using a Perkin–Elmer-341 MC digital 
polarimeter; [α]D-values are given in the unit of 10 deg
−1·cm
2·g
−1. CD was measured with an OLIS, 
DSM-10 UV/Vis CD.  
Silica gel 60 (Merck, 230–400 mesh) and Sephadex LH-20 (Sigma) were used for column 
chromatography. Pre-coated silica gel plates (Merck, Kieselgel 60 F254, 0.25 mm) were used for TLC 
analyses. Spots were visualized by heating after spraying with 10% H2SO4. 
3.2. Animal Material 
Soft coral S. glaucum was collected from the Egyptian Red Sea coast of Hurghada in June, 2009.  
A voucher specimen (03RS24) was deposited in the National Institute of Oceanography and Fisheries, 
Marine Biological Station, Hurghada, Egypt.  
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Control
1
2
3
4
5
mEH activity (µM DHC/min/mg protein)
*
C Mar. Drugs 2012, 10 
 
 
218
3.3. Extraction and Separation 
The frozen soft coral was chopped into small pieces (4 kg, wet weight) and extracted with ethyl 
acetate at room temperature (4 L × 5). The combined ethyl acetate extracts were concentrated to a 
brown gum. The dried EtOAc-soluble material (20.0 g) was subjected to gravity chromatography on 
silica gel column (6 × 120 cm) using n-hexane–EtOAc (gradient separation) into 8 fractions. Fraction 3 
(2.2 g) eluted with n-hexane–EtOAc (8:1) was subjected to silica gel column separation to afford 5  
(50 mg). The remaining samples of this fraction were collected and purified by Sephadex LH-20 using 
hexane–CHCl3–MeOH (7:4:0.5) followed by reverse phase HPLC using acetonitrile H2O (1:1) to 
afford  1  (35 mg), 2  (23 mg) and 3 (14 mg). Fraction 4 eluted with n-hexane–EtOAc (6:1) was   
re-purified on reverse phase HPLC using acetonitrile/H2O (50–100% H2O) 4 (9 mg).  
11-hydroperoxylsarcoph-11(20)-ene (1): colorless crystal; []
25
D α  = +12.6 (c 0.09, CHCl3); IR (KBr) 
νmax 3353, 3000, 1750, 1707, 1686, 1669, 1256 cm
−1; 
1H NMR and 
13C NMR data, see Table 1;  
HR-FAB-MS [M + Na]
+ m/z 371.18281 (41%) (calc. 371.18284, C20H28O5Na). 
3.3.1. Single-Crystal X-ray Crystallography of 1 
X-ray intensity data were measured on a Bruker Smart Apex II automated X-ray diffractometer 
equipped with a CCD detector. The frames were integrated with the Bruker SAINT Software package 
(Version 6) using a narrow-frame algorithm. Integration of the data using a monoclinic unit cell 
yielded a total of 4644 reflections to a maximum θ angle of 18.45° (1.12 Å resolution), of which 1364 
were independent (average redundancy 3.405, completeness = 99.9%, Rint = 3.57%, Rsig = 3.55%) and 
1257 (92.16%) had intensities greater than 2σ(F2). The final cell constants are based upon the 
refinement of the XYZ-centroids of 56 reflections with intensities greater than 20 σ(I) and 2θ values in 
the range 6.72° < 2θ < 23.48°. The calculated minimum and maximum transmission coefficients 
(based on crystal size) are 0.9274 and 0.9982, respectively. 
The structure was solved and refined using the Bruker SHELXTL Software Package in the space 
group P21 (No. 4 in the International Tables for X-ray Crystallography [29]), with Z = 2 for the 
formula C20H28O5. The final anisotropic full-matrix least-squares refinement on F2 with 339 variables 
converged at R1 = 2.54% for the observed data (intensities greater than 4σ(F2)) and wR2 = 5.13% for 
all data, with a goodness-of-fit value of 1.075. The largest peak in the final difference electron density 
synthesis was 0.071 e
−/Å3, and the largest hole was −0.079 e
−/Å3, with an RMS deviation of 
0.020 e
−/Å3. 
12-Hydroperoxylsarcoph-10-ene (2): colorless crystal; []
25
D α  = −20.1 (c 0.1, CHCl3); IR (KBr) νmax 
3353, 3000,  1750, 1707, 1686, 1669, 1256 cm
−1; 
1H NMR and 
13C NMR data, see Table 1;   
HR-FAB-MS [M + Na]
+ m/z 371.18293 (33%) (calc. 371.18290, C20H28O5Na). 
3.3.2. Single-Crystal X-ray Crystallography of 2 
X-ray intensity data were measured on a Bruker Smart Apex II automated X-ray diffractometer 
equipped with a CCD detector. The frames were integrated with the Bruker SAINT Software package 
(Version 6) using a narrow-frame algorithm. Integration of the data using an orthorhombic unit cell Mar. Drugs 2012, 10 
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yielded a total of 9176 reflections to a maximum θ angle of 17.97° (1.15 Å resolution), of which 1332 
were independent (average redundancy 6.889, completeness = 100%, Rint = 4.16%, Rsig = 2.43%) and 
1255 (94.22%) had intensities greater than 2σ(F2). The final cell constants are based upon the 
refinement of the XYZ-centroids of 105 reflections with intensities greater than 20 σ(I) and 2θ values 
in the range 4.15° < 2θ < 36.10°. Data were corrected for absorption effects using the multi-scan 
method (SADABS). The ratio of minimum to maximum apparent transmission was 0.899. The 
structure was solved and refined using the Bruker SHELXTL Software Package in the space group 
P212121 (No. 19 in the International Tables for X-ray Crystallography [29]), with Z = 4 for the 
formula C20H28O5. The final anisotropic full-matrix least-squares refinement on F2 with 235 variables 
converged at R1 = 2.15% for the observed data (intensities greater than 4σ(F2)) and wR2 = 4.66% for 
all data, with a goodness-of-fit value of 1.042 and a data-to-parameter ratio of 5.7. The largest peak in 
the final difference electron density synthesis was 0.069 e
−/Å3, and the largest hole was −0.079 e
−/Å3, 
with an RMS deviation of 0.017 e
−/Å3. 
8-epi-Sarcophinone (3): colorless crystal; []
25
D α  = +19.2 (c 0.1, CHCl3); IR (KBr) νmax 1730, 1700, 
1410, 1230, 960 cm
−1; 
1H NMR and 
13C NMR data, see Table 1; HR-FAB-MS [M + Na]
+  
m/z 339.19313 (100%) (calc. 339.19317, C20H28O5Na). 
ent-Sarcophine (4): []
25
D α  = −20.0 (c 0.03, CHCl3); lit. []
25
D α  = −80.0 (c 0.3, CHCl3) [19]. 
(+)-Sarcophine (5): []
25
D α  = +95.0 (c 0.5, CHCl3); lit. []
25
D α  = +92 (c 1.0, CHCl3) [20]. 
3.4. Cell Culture 
Murine hepatoma cells (Hepa1c1c7) was purchased from the American Type Culture Collection. 
Cells were cultured on Dulbeco’s Modified Eagle’s medium (DMEM). Media were supplemented with 
10% fetal bovine serum (FBS), 2 mM L-glutamine, containing 100 U/mL penicillin G sodium,   
100 U/mL streptomycin sulfate, and 250 ng/mL amphotericin B. Cells were maintained in humidified 
air containing 5% CO2 at 37 °C. The monolayer cells were harvested using trypsin/EDTA. All 
experiments were repeated four times, unless mentioned, and the data were represented as mean ± SD. 
The extract, fractions and compounds were dissolved in DMSO (99.9%) and diluted 1000 fold for each 
assay. In all cellular experiments, results were compared with DMSO-treated cells. All cell culture 
material was obtained from Cambrex, BioScience (Copenhagen, Denmark).  
3.5. Evaluation of Carcinogen Metabolizing Enzymes  
Cytochrome P450 1A (Cyp1A) activity was determined by the rate of dealkylation of   
3-cyano-7-ethoxycoumarin (CEC) to the fluorescent 3-cyano-7-hydroxycoumarin based on   
Crespi et al. [30], and modified by Gerhäuser et al. [31]. Homogenates from cultured Hepa1c1c7 cells, 
induced with β-naphthoflavone (1 µg/mL final concentration) were used as a source of Cyp1A. The 
rate of CEC conversion was measured kinetically at excitation 408/20 nm and emission 460/40 nm by 
a microplate fluorescence reader (FluoStarOptima, BMG lab technologies, Durham, NC, USA). 
Inhibition of Cyp1A activity was calculated in comparison with the initial fluorescence of a complete 
reaction mixture with cell homogenate and buffer instead of the assay compound. Mar. Drugs 2012, 10 
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Hepa1c1c7 cells (1 × 10
6) were incubated with the compounds (10 µg/mL) for 48 h.   
Glutathione-S-transferase (GST) activity was measured in the cell lysate according to Habig et al. [32] 
and based on GST-catalyzed reaction between GSH and 1-chloro-2,4-dinitrobenzene that acts as an 
electrophilic substrate for GST. In the kinetic analysis, the absorbance was assessed at 340 nm. GSTs 
were normalized to the protein content as measured by bicinchoninic acid assay [33]. Quinone 
reductase (QR) activity was determined by measuring the reduction of 2,6-dichloroindophenol [34]. 
The specific QR activity was expressed as nmol of 2,6-dichloroindophenol reduced by 1 mg of protein 
within 1 min. Enzyme activity for mEH was assessed by the production rate of 7-(29,39-dihydroxy) 
propoxycoumarin (DHC) from 7-glycidoxycoumarin (GOC), as described by Inoue et al. [35]. The 
fluorescence intensity was measured at excitation 325 nm and emission 391 nm. DHC in methanol was 
used as a standard. The enzyme activity was expressed as µM DHC/min/mg protein. 
3.6. Statistical Analysis 
Data were analyzed by a one-way ANOVA followed by a post hoc Turkey test; p < 0.05 indicated 
statistical significance. 
4. Conclusions 
Three new (1–3) and two known cembranolides (4 and 5) were isolated and chemically characterized 
from the Red Sea soft coral Sarcophyton glaucum. The absolute configuration of 1 and 2 were 
confirmed by X-ray diffraction and circular dichroism (CD) analyses. Compounds 2 and 3 were found 
to be promising inhibitors of cytochrome P450 1A activity as well as inducers of GST and QR activity 
in in vitro assays. 
Acknowledgements 
Financial assistance was provided in part by a grant from the Robert Welch Foundation (D-1478). 
References 
1.  Edwards, A.J.; Head, S.M. Key Environments-Red Sea; Pergamon Press: Oxford, UK, 1987;   
p. 440. 
2.  Roethle, P.A.; Trauner, D. The chemistry of marine furanocembranoids, pseudopteranes, 
gersolanes, and related natural products. Nat. Prod. Rep. 2008, 25, 298–317.  
3.  Blunt, J.W.; Copp, B.R.; Hu, W.P.; Munro, M.H.G.; Northcote, P.T.; Prinsep, M.R. Marine 
natural products. Nat. Prod. Rep. 2008, 25, 35–94. 
4.  Gross, H.; Wright, A.D.; Beil, W.; Koenig, G.M. Two new bicyclic cembranolides from a new 
Sarcophyton species and determination of the absolute configuration of sarcoglaucol-16-one. Org. 
Biomol. Chem. 2004, 2, 1133–1138.  
5.  Sawant, S.; Youssef, D.; Mayer, A.; Sylvester, P.; Wali, V.; Arant, M.; El Sayed, K. Anticancer 
and anti-inflammatory sulfur-containing semisynthetic derivatives of sarcophine. Chem. Pharm. 
Bull. 2006, 54, 1119–1123.  Mar. Drugs 2012, 10 
 
 
221
6.  Sawant, S.S.; Youssef, D.T.A.; Reiland, J.; Ferniz, M.; Marchetti, D.; El Sayed, K.A. Biocatalytic 
and antimetastatic studies of the marine cembranoids sarcophine and 2-epi-16-deoxysarcophine.  
J. Nat. Prod. 2006, 69, 1010–1013. 
7.  Wahlberg, I.; Eklund, A.M. Cembranoids, pseudopteranoids, and cubitanoids of natural 
occurrence. Prog. Chem. Org. Nat. 1992, 59, 141–294. 
8.  El Sayed, K.A.; Hamann, M.T.; Waddling, C.A.; Jensen, C.; Lee, S.K.; Dunstan, C.A.;   
Pezzuto, J.M. Structurally novel bioconversion products of the marine natural product sarcophine 
effectively inhibit JB6 cell transformation. J. Org. Chem. 1998, 63, 7449–7455. 
9.  Grote, D.; Soliman, H.S.M.; Shaker, K.H.; Hamza, M.; Seifert, K. Cembranoid diterpenes and a 
briarane diterpene from corals. Nat. Prod. Res. 2005, 20, 285–291. 
10.  Neeman, I.; Fishelson, I.; Kashman, Y. Sarcophine—a new toxin from the soft coral Sarcophyton 
glaucum (alcyonaria). Toxicon 1974, 12, 593–598.  
11.  Erman, A.; Neeman, I. Inhibition of phosphofructokinase by the toxic cembranolide sarcophine 
isolated from the soft-bodied coral Sarcophyton glaucum. Toxicon 1976, 15, 207–215. 
12.  El Sayed, K.A.; Orabi, K.Y.; Dunbar, D.C.; Hammann, M.T.; Avery, M.A.; Sabnis, Y.A.;   
Mossa, J.S.; El feraly, F.S. Transformation of lactone to lactam in sarcophine and antimalarial 
activity of resulting N-substituted azasarcophines. Tetrahedron 2002, 58, 3699–3708. 
13.  Fahmy, H.; Khalifa, S.I.; Konoshima, T.; Zjawiony, J.K. An improved synthesis of   
7,8-epoxy-1,3,11-cembratriene-15R(α),16-diol, a cembranoid of marine origin with a potent 
cancer chemopreventive activity. Mar. Drugs 2004, 2, 1–7.  
14.  Katsuyama, I.; Fahmy, H.; Zjawiony, J.K.; Khalifa, S.I.; Kilada, R.W.; Konoshima, T.;   
Takasaki, M.; Harakuni, T. Semisynthesis of new sarcophine derivatives with chemopreventive 
activity. J. Nat. Prod. 2002, 65, 1809–1814.  
15.  Abouzied, A.M.; Sawant, S.S.; Sylvester, P.W.; Avery, M.A.; Desai, P.; Youssef, D.T.A.;   
El Sayed, K.A. Bioactive rearranged and halogenated semisynthetic derivatives of the marine 
natural product sarcophine. J. Nat. Prod. 2004, 67, 2017–2023. 
16.  Hong, W.K.; Sporn, M.B. Recent advances in chemoprevention of cancer. Science 1997, 278, 
1073–1077. 
17.  Arif, J.M.; Al-Hazzani, A.A; Kunhi, M.; Al-Khodairy, F. Novel marine compounds: Anticancer or 
genotoxic? J. Biomed. Biotechnol. 2004, 2, 93–98. 
18.  Yin, S.W.; Shi, Y.P.; Li, X.M.; Wang, B.G. A novel hydroperoxyl-substituted cembranolide 
diterpene from marine soft coral Lobophytum crassum. Chin. Chem. Lett. 2005, 1, 1489–1491. 
19.  Yao, L.-G.; Liu, H.L.; Guo, Y.W.; Mollo, E. New cembranoids from the hainan soft coral 
Sarcophyton glaucum. Helv. Chim. Acta 2009, 92, 1085–1091.  
20.  Bowden, B.F.; Coll, J.C.; Mitchell, S.J. Studies of Australian soft corals. XVIII. Further 
cembranoid diterpenes from soft corals of the genus Sarcophyton.  Aust. J. Chem.  1980, 33,  
879–884. 
21.  Kashman, Y.; Zadock, E.; Neeman, I. New cembrane derivatives of marine origin. Tetrahedron 
1974, 30, 3615–3620. 
22.  Kamel, H.N.; Ferreira, D.; Garcia-Fernandez, L.F.; Slattery, M. Cytotoxic diterpenoids from the 
hybrid soft coral Sinularia maxima × Sinularia polydactyla. J. Nat. Prod. 2007, 70, 1223–1227. Mar. Drugs 2012, 10 
 
 
222
23.  Su, J.Y.; Yan, S.J.; Zeng, L.M. New diterpene lactone from the soft coral Sarcophyton molle Tix. 
Dur. Chem. J. Chin. Univ. 2001, 22, 1515–1517.  
24.  Nii, K.; Tagami, K.; Kijima, M.; Munakata, T.; Ooi, T.; Kusumi, T. Acid-catalyzed reactions of 
sarcophytoxide, a marine cembranoid: An apparently enantio-directive reaction, unusual products 
and stereochemical reconsideration of epoxide-ketone rearrangement. Bull. Chem. Soc. Jpn. 2008, 
81, 562–573.  
25.  Czarkie, D.; Carmely, S.; Groweiss, A.; Kashman, Y. Attempted acid-catalyzed transannular 
reactions in the cembranoids. Tetrahedron 1985, 41, 1049–1056. 
26.  Swapnali, S.S.; Sylvester, P.W.; Avery, M.A.; Desai, P.; Youssef, D.T.A.; El Sayed, K.A. 
Bioactive rearranged and halogenated semisynthetic derivatives of the marine natural product 
sarcophine. J. Nat. Prod. 2004, 67, 2017–2023.  
27.  Rooseboom, M.; Commandeur, J.N.M.; Vermeulen, N.P.E. Enzyme-catalyzed activation of 
anticancer prodrugs. Pharmacol. Rev. 2004, 56, 53–102. 
28.  Cannady, E.A.; Dyer, C.A.; Christian, P.J., Sipes, G.; Hoyer, P.B. Expression and activity of 
microsomal epoxide hydrolase in follicles isolated from mouse ovaries. Toxicol. Sci. 2002, 68,  
24–31.  
29.  Henry, N.F.M.; Lonsdale, K. International Tables for X-ray Crystallography; Kynoch Press: 
Birmingham, UK, 1952; Volume 1, p. 78. 
30.  Crespi, C.L.; Miller, V.P.; Penman, B.W. Microtiter plate assays for inhibition of human,   
drug-metabolizing cytochromes P450. Anal. Biochem. 1997, 248, 188–190. 
31.  Gerhäuser, C.; Klimo, K.; Heiss, E.; Neumann, I.; Gamal-Eldeen, A.; Knauft, J.; Liu, J.-U.; 
Sitthimonchai, S.; Frank, N. Mechanism-based in vitro screening of potential cancer 
chemopreventive agents. Mutat. Res. 2003, 523–524, 163–172. 
32.  Habig, W.H.; Pabst, M.J.; Jakoby, W.B. Glutathione S-transferases. The first enzymatic step in 
mercapturic acid formation. J. Biol. Chem. 1974, 249, 7130–7139.  
33.  Smith, P.K.; Krohn, R.I.; Hermanson, G.T.; Mallia, A.K.; Gartner, F.H.; Provenzano, M.D.; 
Fujimoto, E.K.; Goeke, N.M.; Olson, B.J.; Klenk, D.C. Measurement of protein using 
bicinchoninic acid. Anal. Biochem. 1985, 150, 76–85.  
34.  Yu, R.; Mandlekar, S.; Lei, W.; Fahl, W.E.; Tan, T.-H.; Kong, A.T. p38 Mitogen-activated 
protein kinase negatively regulates the induction of phase II drug-metabolizing enzymes that 
detoxify carcinogens. J. Biol. Chem. 2000, 275, 2322–2327. 
35.  Inoue, N.; Yamada, K.; Imai, K.; Aimoto, T. Sex hormone-related control of hepatic EH activities 
in mice. Biol. Pharm. Bull. 1993, 16, 1004–1007. 
Samples Availability: Available from the authors. 
© 2012 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 